Spelling suggestions: "subject:"nasopharyngeale"" "subject:"nasopharyngealem""
51 |
Curcumin inhibits cell migration of nasopharyngeal carcinoma through reactivation of e-cadherin expressionChan, Wing-san, 陳詠珊 January 2009 (has links)
published_or_final_version / Surgery / Master / Master of Philosophy
|
52 |
Oral health and quality of life after intensity-modulated head and neck radiotherapy for nasopharyngeal carcinomaPow, Ho-nang, Edmond., 鮑浩能. January 2006 (has links)
published_or_final_version / Dentistry / Doctoral / Doctor of Philosophy
|
53 |
Hypothalamic-pituitary function following cranial irradiation for nasopharyngeal carcinoma林小玲, Lam, Siu-ling, Karen. January 1990 (has links)
published_or_final_version / Medicine / Master / Doctor of Medicine
|
54 |
Lanthanide-based nanomaterials for imaging and inhibition of EBV-related cancersZha, Shuai 12 June 2020 (has links)
Nasopharyngeal Carcinoma (NPC) as a typical malignancy that occurs in high-incidence areas, e.g. southern China region, including Hong Kong, and it has aroused wide interests for local researchers to study. The Epstein-Barr virus (EBV) was reported as a vital herpes virus for the growth of NPC. Two significant proteins in EBV, namely Epstein-Barr Nuclear Antigen 1 (EBNA1) and latent infection membrane protein 1 (LMP1) are crucial for virus maintenance and EBV-infected cell development, and essential for cell proliferation and differentiation of EBV latent life cycle, respectively. Thus, inhibition of EBNA1 and LMP1 can be regarded as effective and potent therapy on EBV-associated cancers. In this thesis, the conjugation of core-shell structured upconversion nanoparticles (UCNPs) with distinct EBV-specific peptides including EBNA1 and LMP1 targeting peptides to achieve both impressive inhibition on EBV-positive cancers in vitro/in vivo and visualization on EBV-positive cells with responsive upconversion emission signals were investigated. Taking advantage of lanthanide-based UCNPs, their unique photophysical properties offer deep tissue penetration depth, negligible photobleaching and photocytotoxicity, and therefore provides a solid foundation for convincible theranostic studies. Furthermore, desired inhibitory performance was achieved, it was shown that ~50 mg/mL of nanoprobes can inhibit half of EBV-infected cell viability and only 0.25 mg/tumor of nanoprobes dosage via intravenous injection can prohibit 64.7% of growth inhibition of an EBV-positive tumor
|
55 |
Biological properties of EBV-encoded latent membrane protein 1 in nasopharyngeal epithelial cellsLiu, Yu, 劉鈺 January 2000 (has links)
published_or_final_version / Anatomy / Doctoral / Doctor of Philosophy
|
56 |
Development of DNA vaccines encoding Epstein-Barr virus (EBV)-specificantigens potentially for EBV-associated nasopharyngeal carcinoma (NPC)immunotherapyLing, Guangsheng., 寧珖聖. January 2005 (has links)
published_or_final_version / abstract / Surgery / Master / Master of Philosophy
|
57 |
BARF1 sequence analysis and functional significance in EBV-Related disordersLiu, Xuan, 劉絢 January 2005 (has links)
published_or_final_version / abstract / Pathology / Master / Master of Philosophy
|
58 |
Induction of genomic instability and mitotic dysregulation in immortalized nasopharyngeal epithelial cellsMan, Wing-yin, Cornelia., 文詠賢. January 2007 (has links)
published_or_final_version / abstract / Anatomy / Doctoral / Doctor of Philosophy
|
59 |
Significance of mitotic checkpoint regulatory proteins in chemosensitivity of nasopharyngeal carcinoma cellsCheung, Hiu-wing., 張曉穎. January 2006 (has links)
published_or_final_version / abstract / Anatomy / Doctoral / Doctor of Philosophy
|
60 |
Is waiting time a quality service indicator for radiotherapytreatment?: the effect of waiting time onlocal tumour control for nasopharyngeal carcinoma patients in HongKongTze, Mei-yu, Jadie., 謝美瑜. January 2006 (has links)
published_or_final_version / Community Medicine / Master / Master of Public Health
|
Page generated in 0.0312 seconds